Knowledge (XXG)

TRPM3-related neurodevelopmental disorder

Source 📝

193:. The mutations produce increased basal activity of the TRPM3 ion channel as well as increased response to chemical and noxious heat stimuli. The gain-of-function results in increased intracellular Ca. It is possible that this increased channel activity and/or Ca induced nerve damage could be the underlying mechanism of the disease. 229:
There is currently no known cure or treatment for TRPM3-related neurodevelopmental disorder. Treatment for individual manifestations of symptoms may follow standard of care (
843:
Sundaramurthi, JC; Bagley, AM; Blau, H; Carmody, L; Crandall, A; Danis, D; Gargano, M; Gustafson, AG; Raney, EM; Shingle, M; Davids, JR; Robinson, PN (8 September 2023).
972: 221:. Following identification of a mutation in the TRPM3 gene, alterations in channel activity are evaluated using electrophysiological assays and calcium imaging 272:
Life span is apparently not impacted by TRPM3-related neurodevelopmental disorder. Not enough data currently exists to understand the disease progression.
1007: 280:
There are currently >30 reported cases of TRPM3-related neurodevelopmental disorder. It is unknown what the prevalence of this disorder is worldwide.
1022: 992: 492:"Phenotypic spectrum of the recurrent TRPM3 p.( Val837Met ) substitution in seven individuals with global developmental delay and hypotonia" 594:
Van Hoeymissen, Evelien; Held, Katharina; Nogueira Freitas, Ana Cristina; Janssens, Annelies; Voets, Thomas; Vriens, Joris (19 May 2020).
987: 916: 751:
Gauthier, LW; Chatron, N; Cabet, S; Labalme, A; Carneiro, M; Poirot, I; Delvert, C; Gleizal, A; Lesca, G; Putoux, A (November 2021).
794:"A Chinese patient with developmental and epileptic encephalopathies (DEE) carrying a TRPM3 gene mutation: a paediatric case report" 1002: 655:"Primidone improves symptoms in TRPM3-linked developmental and epileptic encephalopathy with spike-and-wave activation in sleep" 997: 977: 982: 491: 596:"Gain of channel function and modified gating properties in TRPM3 mutants causing intellectual disability and epilepsy" 1017: 179: 109: 61: 1012: 230: 845:"De novo TRPM3 missense variant associated with neurodevelopmental delay and manifestations of cerebral palsy" 376:"Gain-of-function variants in the ion channel gene TRPM3 underlie a spectrum of neurodevelopmental disorders" 967: 206: 113: 105: 65: 542:"Disease-associated mutations in the human TRPM3 render the channel overactive via two distinct mechanisms" 218: 53: 242: 97: 45: 174:
gene. Since the general population has numerous truncating variants and microdeletions throughout
884: 684: 519: 467: 183: 160: 876: 825: 774: 733: 676: 635: 617: 573: 511: 459: 407: 339: 30: 866: 856: 815: 805: 764: 723: 715: 666: 625: 607: 563: 553: 503: 449: 441: 397: 387: 238: 190: 163: 253: 202: 871: 844: 820: 793: 792:
Kang, Q; Yang, L; Liao, H; Yang, S; Kuang, X; Ning, Z; Liao, C; Chen, B (1 June 2021).
728: 703: 630: 595: 568: 541: 454: 429: 402: 375: 246: 49: 961: 888: 688: 523: 471: 132: 719: 945: 940: 335: 810: 769: 752: 445: 428:
Dyment, David A.; Terhal, Paulien A.; Rustad, Cecilie F.; et al. (2019).
140: 124: 85: 753:"Description of a novel patient with the TRPM3 recurrent p.Val837Met variant" 621: 908: 374:
Burglen, Lydie; Van Hoeymissen, Evelien; Qebibo, Leila; et al. (2023).
257: 144: 136: 128: 101: 81: 77: 57: 880: 829: 778: 737: 702:
Krügel, Ute; Straub, Isabelle; Beckmann, Holger; Schaefer, Michael (2017).
680: 639: 577: 515: 463: 430:"De novo substitutions of TRPM3 cause intellectual disability and epilepsy" 411: 343: 96:
The earliest sign for TRPM3-related neurodevelopmental disorder is usually
507: 234: 210: 167: 117: 69: 861: 612: 558: 490:
Lines, Matthew A.; Goldenberg, Paula; Wong, Ashley; et al. (2022).
392: 653:
Becker, Lena-Luise; Horn, Denise; Boschann, Felix; et al. (2023).
671: 654: 704:"Primidone inhibits TRPM3 and attenuates thermal nociception in vivo" 148: 73: 189:
Research has shown that the disease-associated mutations lead to a
261: 214: 175: 171: 921: 334:
Dyment, David; Lines, Matthew; Innes, A Micheil (2023-02-23).
123:
Other signs of TRPM3-related neurodevelopmental disorder are
294: 72:, musculoskeletal anomalies, altered pain perception, 898: 931: 902: 540:Zhao, Siyuan; Yudin, Yevgen; Rohacs, Tibor (2020). 112:is nearly always present along with mild-to-severe 29: 24: 260:as an off label therapeutic. Primidone is a known 159:TRPM3-related neurodevelopmental disorder is an 589: 587: 8: 496:American Journal of Medical Genetics Part A 336:"TRPM3-Related Neurodevelopmental Disorder" 899: 21: 946:TRPM3-Related Neurodevelopmental Disorder 870: 860: 849:Cold Spring Harbor Molecular Case Studies 819: 809: 768: 727: 670: 629: 611: 567: 557: 453: 401: 391: 369: 367: 365: 363: 361: 359: 357: 355: 353: 42:TRPM3-related neurodevelopmental disorder 25:TRPM3-related neurodevelopmental disorder 423: 421: 485: 483: 481: 329: 305: 973:Syndromes affecting the nervous system 535: 533: 327: 325: 323: 321: 319: 317: 315: 313: 311: 309: 338:. University of Washington, Seattle. 7: 757:European Journal of Medical Genetics 434:European Journal of Human Genetics 100:. Infant feeding issues including 14: 1008:Pervasive developmental disorders 720:10.1097/j.pain.0000000000000846 178:, the underlying mechanism for 151:, and altered pain perception. 1023:Genetic diseases and disorders 213:multigene panel that includes 1: 252:A single study points to the 120:is reported in 50% of cases. 993:Autosomal dominant disorders 48:developmental and epileptic 180:neurodevelopmental disorder 1039: 988:Disorders causing seizures 811:10.1186/s12887-021-02719-8 770:10.1016/j.ejmg.2021.104320 201:Diagnosis is made through 110:Global developmental delay 62:global developmental delay 446:10.1038/s41431-019-0462-x 231:anti-epileptic medication 1003:Intellectual disability 207:intellectual disability 114:intellectual disability 106:gastroesophageal reflux 66:intellectual disability 998:Neurogenetic disorders 978:Neurological disorders 219:whole exome sequencing 54:central nervous system 983:Learning disabilities 508:10.1002/ajmg.a.62673 243:occupational therapy 98:congenital hypotonia 862:10.1101/mcs.a006293 613:10.7554/eLife.57190 559:10.7554/elife.55634 393:10.7554/elife.81032 108:are also reported. 1018:Genetics of autism 932:External resources 855:(4): mcs.a006293. 184:haploinsufficiency 166:. It is caused by 161:autosomal dominant 92:Signs and Symptoms 955: 954: 672:10.1111/epi.17586 440:(10): 1611–1618. 170:mutations in the 127:facial features, 52:that affects the 39: 38: 19:Medical condition 1030: 1013:Syndromic autism 900: 893: 892: 874: 864: 840: 834: 833: 823: 813: 789: 783: 782: 772: 748: 742: 741: 731: 699: 693: 692: 674: 650: 644: 643: 633: 615: 591: 582: 581: 571: 561: 537: 528: 527: 502:(6): 1667–1675. 487: 476: 475: 457: 425: 416: 415: 405: 395: 371: 348: 347: 331: 295:TRPM3 Foundation 239:physical therapy 191:gain-of-function 164:genetic disorder 22: 1038: 1037: 1033: 1032: 1031: 1029: 1028: 1027: 958: 957: 956: 951: 950: 927: 926: 911: 897: 896: 842: 841: 837: 791: 790: 786: 750: 749: 745: 701: 700: 696: 652: 651: 647: 593: 592: 585: 539: 538: 531: 489: 488: 479: 427: 426: 419: 373: 372: 351: 333: 332: 307: 302: 292: 290:Other Resources 286: 283: 278: 270: 254:anti-convulsant 227: 203:genetic testing 199: 157: 94: 20: 17: 12: 11: 5: 1036: 1034: 1026: 1025: 1020: 1015: 1010: 1005: 1000: 995: 990: 985: 980: 975: 970: 968:Rare syndromes 960: 959: 953: 952: 949: 948: 936: 935: 933: 929: 928: 925: 924: 912: 907: 906: 904: 903:Classification 895: 894: 835: 798:BMC Pediatrics 784: 763:(11): 104320. 743: 714:(5): 856–867. 694: 665:(5): e61–e68. 645: 583: 529: 477: 417: 349: 304: 303: 301: 298: 291: 288: 277: 274: 269: 266: 247:speech therapy 226: 223: 198: 195: 156: 153: 93: 90: 50:encephalopathy 37: 36: 33: 27: 26: 18: 15: 13: 10: 9: 6: 4: 3: 2: 1035: 1024: 1021: 1019: 1016: 1014: 1011: 1009: 1006: 1004: 1001: 999: 996: 994: 991: 989: 986: 984: 981: 979: 976: 974: 971: 969: 966: 965: 963: 947: 943: 942: 938: 937: 934: 930: 923: 919: 918: 914: 913: 910: 905: 901: 890: 886: 882: 878: 873: 868: 863: 858: 854: 850: 846: 839: 836: 831: 827: 822: 817: 812: 807: 803: 799: 795: 788: 785: 780: 776: 771: 766: 762: 758: 754: 747: 744: 739: 735: 730: 725: 721: 717: 713: 709: 705: 698: 695: 690: 686: 682: 678: 673: 668: 664: 660: 656: 649: 646: 641: 637: 632: 627: 623: 619: 614: 609: 605: 601: 597: 590: 588: 584: 579: 575: 570: 565: 560: 555: 551: 547: 543: 536: 534: 530: 525: 521: 517: 513: 509: 505: 501: 497: 493: 486: 484: 482: 478: 473: 469: 465: 461: 456: 451: 447: 443: 439: 435: 431: 424: 422: 418: 413: 409: 404: 399: 394: 389: 385: 381: 377: 370: 368: 366: 364: 362: 360: 358: 356: 354: 350: 345: 341: 337: 330: 328: 326: 324: 322: 320: 318: 316: 314: 312: 310: 306: 299: 297: 296: 289: 287: 284: 281: 275: 273: 267: 265: 263: 259: 255: 250: 248: 244: 240: 236: 232: 224: 222: 220: 216: 212: 208: 204: 196: 194: 192: 187: 185: 181: 177: 173: 169: 165: 162: 154: 152: 150: 146: 142: 138: 134: 133:hip dysplasia 130: 126: 121: 119: 115: 111: 107: 103: 99: 91: 89: 87: 83: 79: 75: 71: 67: 63: 59: 55: 51: 47: 43: 34: 32: 28: 23: 939: 915: 852: 848: 838: 801: 797: 787: 760: 756: 746: 711: 707: 697: 662: 658: 648: 603: 599: 549: 545: 499: 495: 437: 433: 383: 379: 293: 285: 282: 279: 276:Epidemiology 271: 264:antagonist. 251: 228: 200: 188: 158: 122: 95: 56:. The broad 41: 40: 16:Rare disease 941:GeneReviews 46:monogenetic 962:Categories 804:(1): 256. 606:: e57190. 300:References 141:strabismus 125:dysmorphic 86:cerebellar 889:261620692 689:257581570 659:Epilepsia 622:2050-084X 524:246749002 472:195804345 268:Prognosis 258:primidone 225:Treatment 205:using an 197:Diagnosis 145:nystagmus 137:exotropia 129:scoliosis 102:dysphagia 88:atrophy. 82:nystagmus 78:hypotonia 60:includes 58:phenotype 35:Neurology 31:Specialty 881:37684057 872:10815282 830:34074259 779:34438093 738:28106668 681:36929095 640:32427099 578:32343227 516:35146895 464:31278393 412:36648066 344:36821706 249:, etc). 235:seizures 211:epilepsy 168:missense 118:Epilepsy 70:epilepsy 821:8167971 729:5402713 631:7253177 569:7255801 455:6777445 403:9886277 182:is not 922:620224 887:  879:  869:  828:  818:  777:  736:  726:  687:  679:  638:  628:  620:  576:  566:  522:  514:  470:  462:  452:  410:  400:  342:  149:ataxia 84:, and 74:ataxia 885:S2CID 685:S2CID 600:eLife 546:eLife 520:S2CID 468:S2CID 380:eLife 262:TRPM3 256:drug 215:TRPM3 176:TRPM3 172:TRPM3 155:Cause 44:is a 917:OMIM 877:PMID 826:PMID 775:PMID 734:PMID 708:Pain 677:PMID 636:PMID 618:ISSN 574:PMID 512:PMID 460:PMID 408:PMID 340:PMID 233:for 104:and 867:PMC 857:doi 816:PMC 806:doi 765:doi 724:PMC 716:doi 712:158 667:doi 626:PMC 608:doi 564:PMC 554:doi 504:doi 500:188 450:PMC 442:doi 398:PMC 388:doi 217:or 209:or 964:: 944:: 920:: 883:. 875:. 865:. 851:. 847:. 824:. 814:. 802:21 800:. 796:. 773:. 761:64 759:. 755:. 732:. 722:. 710:. 706:. 683:. 675:. 663:64 661:. 657:. 634:. 624:. 616:. 602:. 598:. 586:^ 572:. 562:. 552:. 548:. 544:. 532:^ 518:. 510:. 498:. 494:. 480:^ 466:. 458:. 448:. 438:27 436:. 432:. 420:^ 406:. 396:. 386:. 384:12 382:. 378:. 352:^ 308:^ 245:, 241:, 237:, 186:. 147:, 143:, 139:, 135:, 131:, 116:. 80:, 76:, 68:, 64:, 909:D 891:. 859:: 853:9 832:. 808:: 781:. 767:: 740:. 718:: 691:. 669:: 642:. 610:: 604:9 580:. 556:: 550:9 526:. 506:: 474:. 444:: 414:. 390:: 346:.

Index

Specialty
monogenetic
encephalopathy
central nervous system
phenotype
global developmental delay
intellectual disability
epilepsy
ataxia
hypotonia
nystagmus
cerebellar
congenital hypotonia
dysphagia
gastroesophageal reflux
Global developmental delay
intellectual disability
Epilepsy
dysmorphic
scoliosis
hip dysplasia
exotropia
strabismus
nystagmus
ataxia
autosomal dominant
genetic disorder
missense
TRPM3
TRPM3

Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.